These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25535398)

  • 1. INTRAGO: intraoperative radiotherapy in glioblastoma multiforme—a phase I/II dose escalation study.
    Giordano FA; Brehmer S; Abo-Madyan Y; Welzel G; Sperk E; Keller A; Schneider F; Clausen S; Herskind C; Schmiedek P; Wenz F
    BMC Cancer; 2014 Dec; 14():992. PubMed ID: 25535398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma (INTRAGO): An Open-Label, Dose-Escalation Phase I/II Trial.
    Giordano FA; Brehmer S; Mürle B; Welzel G; Sperk E; Keller A; Abo-Madyan Y; Scherzinger E; Clausen S; Schneider F; Herskind C; Glas M; Seiz-Rosenhagen M; Groden C; Hänggi D; Schmiedek P; Emami B; Souhami L; Petrecca K; Wenz F
    Neurosurgery; 2019 Jan; 84(1):41-49. PubMed ID: 29528443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal MRI findings in patients with newly diagnosed glioblastoma after intraoperative radiotherapy.
    Förster A; Böhme J; Maros ME; Brehmer S; Seiz-Rosenhagen M; Hänggi D; Wenz F; Groden C; Pope WB; Giordano FA
    J Neuroradiol; 2020 Mar; 47(2):166-173. PubMed ID: 30659892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study Protocol: Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma (Gamma-GBM).
    Brehmer S; Grimm MA; Förster A; Seiz-Rosenhagen M; Welzel G; Stieler F; Wenz F; Groden C; Mai S; Hänggi D; Giordano FA
    Neurosurgery; 2019 May; 84(5):1133-1137. PubMed ID: 29688510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraoperative radiotherapy (IORT) in malignant brain tumors].
    Wagner W; Schüller P; Willich N; Schober O; Palkovic S; Morgenroth C; Bartenstein P; Prott FJ; Niewöhner U
    Strahlenther Onkol; 1995 Mar; 171(3):154-64. PubMed ID: 7709332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial of external beam-radiotherapy combined with daily administration of low-dose cisplatin for supratentorial glioblastoma multiforme--a pilot study.
    Shinoda J; Sakai N; Hara A; Ueda T; Sakai H; Nakatani K
    J Neurooncol; 1997 Oct; 35(1):73-80. PubMed ID: 9266443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary experiences with intraoperative radiation therapy (IORT) for the treatment of brain tumors.
    Chung YG; Kim CY; Lee HK; Lee KC; Chu JW; Choi MS
    J Korean Med Sci; 1995 Dec; 10(6):449-52. PubMed ID: 8924231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.
    Tralins KS; Douglas JG; Stelzer KJ; Mankoff DA; Silbergeld DL; Rostomily RC; Hummel S; Scharnhorst J; Krohn KA; Spence AM
    J Nucl Med; 2002 Dec; 43(12):1667-73. PubMed ID: 12468518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
    Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme.
    Nieder C; Nestle U; Ketter R; Kolles H; Gentner SJ; Steudel WI; Schnabel K
    Radiat Oncol Investig; 1999; 7(1):36-41. PubMed ID: 10030622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
    Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
    Piroth MD; Holy R; Pinkawa M; Stoffels G; Kaiser HJ; Galldiks N; Herzog H; Coenen HH; Eble MJ; Langen KJ
    Radiother Oncol; 2011 May; 99(2):218-24. PubMed ID: 21497925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomas.
    Schueller P; Micke O; Palkovic S; Schroeder J; Moustakis C; Bruns F; Schuck A; Wassmann H; Willich N
    Strahlenther Onkol; 2005 Aug; 181(8):500-6. PubMed ID: 16044217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Dosimetry Formalisms in Intraoperative Radiation Therapy of Glioblastoma.
    Ayala Alvarez DS; Watson PGF; Popovic M; Heng VJ; Evans MDC; Panet-Raymond V; Seuntjens J
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):763-773. PubMed ID: 37150259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical treatment and radiation therapy for glioblastoma multiforme, with special reference to intraoperative radiotherapy].
    Matsutani M; Matsuda T; Nagashima T; Kohno T; Hoshino T; Terao H
    Gan No Rinsho; 1984 Apr; 30(4):325-33. PubMed ID: 6328061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
    Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
    Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALA-RDT in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma.
    Pepper NB; Eich HT; Müther M; Oertel M; Rehn S; Spille DC; Stummer W
    Radiat Oncol; 2024 Jan; 19(1):11. PubMed ID: 38254201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.